Impact of MYC and BCL2 Double Expression on Outcomes in Primary CNS Lymphoma: A UK Multicenter Analysis

被引:0
|
作者
Poynton, Edward [1 ,2 ]
Chernucha, Emily [3 ]
Day, James [2 ]
Prodger, Catherine [4 ]
Hopkins, David [5 ]
Rakesh, Pallav [5 ,6 ]
O'Neill, Tess [7 ]
Thakrar, Nisha [2 ]
Akarca, Ayse [8 ]
Jamal, Esraa [1 ]
Ali, Ayesha [9 ]
Kirkwood, Amy A. [10 ]
Pomplun, Sabine [8 ]
Marafioti, Teresa [8 ]
Calaminici, Maria
Greaves, Paul [11 ]
Chaganti, Sridhar [6 ]
Mckay, Pam
Smith, Jeffery [12 ]
Eyre, Toby A.
Martinez-Calle, Nicolas [3 ]
Cwynarski, Kate [2 ]
Fox, Christopher P. [13 ]
Okosun, Jessica
机构
[1] Queen Mary Univ London, Barts Canc Inst, Ctr Haematooncol, London, England
[2] Univ Coll London Hosp, Dept Clin Haematol, London, England
[3] Nottingham Univ Hosp NHS Trust, Nottingham, England
[4] Oxford Univ Hosp NHS Fdn Trust, Churchill Canc Ctr, Oxford, England
[5] Beatson West Scotland Canc Ctr, Glasgow, Lanark, Scotland
[6] Univ Hosp Birmingham NHS Fdn Trust, Ctr Clin Haematol, Birmingham, W Midlands, England
[7] Barts Hlth NHS Trust, St Bartholomews Hosp, Dept Haemato Oncol, London, England
[8] Univ Coll London Hosp, Dept Histopathol, London, England
[9] Univ Birmingham, Canc Res UK Clin Trials Unit, Birmingham, W Midlands, England
[10] UCL, Canc Res UK, London, England
[11] Barking Havering & Redbridge Univ Hosp NHS Trust, Dept Haematol, London, England
[12] Liverpool Univ Hosp, Clatterbridge Canc Ctr, Liverpool, Merseyside, England
[13] Univ Nottingham, Sch Med, Nottingham, England
关键词
PCNSL; primary CNS Lymphoma; double expressor; MYC; BCL2;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
ABCL-184
引用
收藏
页码:S423 / S424
页数:2
相关论文
共 50 条
  • [21] Prevalence and Prognostic Impact of MYC, BCL2, and BCL6 Rearrangements in Large B Cell Lymphoma Patients: A Multicenter Historical Cohort Study from Iran
    Radmanesh, Fatemeh
    Monabati, Ahmad
    Motavas, Maedeh
    Rezvani, Alireza
    Montazer, Mehdi
    MIDDLE EAST JOURNAL OF CANCER, 2024, 15 (02) : 89 - 97
  • [22] BCL2 inhibition in double hit lymphoma
    Anderson, Mary Ann
    Huang, David C. S.
    Roberts, Andrew W.
    LEUKEMIA & LYMPHOMA, 2015, 56 (07) : 1928 - 1929
  • [23] Double-hit follicular lymphoma with MYC and BCL2 translocations: a study of 7 cases with a review of literature
    Miao, Yuan
    Hu, Shimin
    Lu, Xinyan
    Li, Shaoying
    Wang, Wei
    Medeiros, L. Jeffrey
    Lin, Pei
    HUMAN PATHOLOGY, 2016, 58 : 72 - 77
  • [24] MYC overexpression but not MYC/BCL2 double expression predicts survival in bulky mass diffuse large B-cell lymphoma patients
    Wang, Yanjie
    Liu, Donglin
    Zhang, Xudong
    Zhang, Mingzhi
    Li, Shenglei
    Feng, Xiaoyan
    Dong, Meng
    Ma, Shanshan
    Qian, Siyu
    Wang, Zeyuan
    Zhang, Yue
    Wang, Pengyuan
    Mei, Shuhao
    Chen, Qingjiang
    CANCER MEDICINE, 2023, 12 (18): : 18568 - 18577
  • [25] The prognostic significance of MYC/BCL2 double expression in DLBCL in the genetic classification era
    Wu, Yi-Fan
    Yuan, Qun-Hui
    Shen, Hao-Rui
    Du, Kai-Xin
    Shang, Chun-Yu
    Li, Yue
    Zhang, Xin-Yu
    Wu, Jia-Zhu
    Gao, Rui
    Wang, Li
    Li, Jian-Yong
    Yin, Hua
    Liang, Jin-Hua
    Xu, Wei
    CANCER SCIENCE, 2025, 116 (01) : 257 - 270
  • [26] Challenges and Opportunities for High-grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangement (Double-hit Lymphoma)
    Zeng, Dongfeng
    Desai, Aakash
    Yan, Fangfang
    Gong, Tiejun
    Ye, Haige
    Ahmed, Makhdum
    Nomie, Krystle
    Romaguera, Jorge
    Champlin, Richard
    Li, Shaoying
    Wang, Michael
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2019, 42 (03): : 304 - 316
  • [27] Using Gene Expression Profiling to Move Beyond MYC/BCL2 Rearrangements in High-Grade Lymphoma
    Chan, Wing C.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (03) : 175 - +
  • [28] MYC Cytogenetic Status Correlates With Expression and Has Prognostic Significance in Patients With MYC/BCL2 Protein Double-positive Diffuse Large B-cell Lymphoma
    Wang, Xuan Julia
    Medeiros, L. Jeffrey
    Lin, Pei
    Yin, C. Cameron
    Hu, Shimin
    Thompson, Mary Ann
    Li, Shaoying
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2015, 39 (09) : 1250 - 1258
  • [29] Genetic Subtyping and Phenotypic Characterization of the Immune Microenvironment and MYC/BCL2 Double Expression Reveal Heterogeneity in Diffuse Large B-cell Lymphoma
    Xu-Monette, Zijun Y.
    Wei, Li
    Fang, Xiaosheng
    Au, Qingyan
    Nunns, Harry
    Nagy, Mate
    Tzankov, Alexandar
    Zhu, Feng
    Visco, Carlo
    Bhagat, Govind
    Dybkaer, Karen
    Chiu, April
    Tam, Wayne
    Zu, Youli
    Hsi, Eric D.
    Hagemeister, Fredrick B.
    Sun, Xiaoping
    Han, Xin
    Go, Heounjeong
    Ponzoni, Maurilio
    Ferreri, Andres J. M.
    Moller, Michael B.
    Parsons, Benjamin M.
    van Krieken, J. Han
    Piris, Miguel A.
    Winter, Jane N.
    Li, Yong
    Xu, Bing
    Albitar, Maher
    You, Hua
    Young, Ken H.
    CLINICAL CANCER RESEARCH, 2022, 28 (05) : 972 - 983
  • [30] Clinicopathological features of lymphoma/leukemia patients carrying both BCL2 and MYC translocations
    Tomita, Naoto
    Tokunaka, Mami
    Nakamura, Naoya
    Takeuchi, Kengo
    Koike, Junki
    Motomura, Shigeki
    Miyamoto, Ko
    Kikuchi, Ako
    Hyo, Rie
    Yakushijin, Yoshihiro
    Masaki, Yasufumi
    Fujii, Soichiro
    Hayashi, Takamasa
    Ishigatsubo, Yoshiaki
    Miura, Ikuo
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 (07): : 935 - 943